Samuel Salvaggio, PhD
Senior Trial Design Lead, One2Treat · Lecturer in biostatistics, ULB School of Public Health
I work on how clinical trials measure what matters: which outcomes to choose, how to prioritize them, and how to demonstrate a treatment’s value in terms patients, clinicians and regulators all recognize. I’ve worked across endpoint strategy, trial design and clinical development plans from Phase I to III, in oncology, rare neurological disease and infectious disease.
Selected peer-reviewed publications
- Generalized pairwise comparisons to support shared decision-making in the CODA trial JAMA Network Open, 2025
- Design of a clinical trial using generalized pairwise comparisons to test a less intensive treatment regimen Clinical Trials, 2024
- Generalized pairwise comparisons to assess treatment effects Journal of the American College of Cardiology, 2023
- Generalized pairwise comparisons of prioritized outcomes are a powerful and patient-centric analysis of multi-domain scores Orphanet Journal of Rare Diseases, 2023
- Regulatory considerations for GPC analyses Handbook of Generalized Pairwise Comparisons, Chapman & Hall/CRC, 2025